Clinical Trial Categories
  • Age & Physical Activity (1)
  • Alzheimer's Disease (7)
  • Arthritis (3)
  • Asthma (1)
  • Cancer - Bladder (1)
  • Cancer - Brain & CNS (16)
  • Cancer - Breast (8)
  • Cancer - Colon/Colorectal (2)
  • Cancer - Digestive System (2)
  • Cancer - Female Reproductive (8)
  • Cancer - Gastric (1)
  • Cancer - Kidney (2)
  • Cancer - Leukemia (6)
  • Cancer - Liver (1)
  • Cancer - Lung (3)
  • Cancer - Lymphoma (27)
  • Cancer - Melanoma (15)
  • Cancer - Mesothelioma (2)
  • Cancer - Myeloma (10)
  • Cancer - Other (5)
  • Cancer - Ovarian (2)
  • Cancer - Pancreas (2)
  • Cancer - Peritoneal (5)
  • Cancer - Prostate (12)
  • Cancer - Sarcoma (1)
  • Cancer - Stomach (1)
  • Cancer - Testicular (1)
  • Cancer - Tissue (6)
  • Crohn's Disease (3)
  • Dermatitis (2)
  • Dermatomyositis (1)
  • Healthy (6)
  • Hepatitis C (2)
  • HIV (4)
  • HPV (1)
  • Hypercholesterolemia (1)
  • Immune Disease - Autoimmune (9)
  • Immune Disease - Primary (2)
  • Immune Disease - Secondary (6)
  • Infectious Disease (2)
  • Inflammatory Disease (3)
  • Kidney Transplant (1)
  • Liver Disease (2)
  • Lupus Erythematosus (3)
  • Multiple Sclerosis (3)
  • Neurodegenerative (1)
  • OX40 (1)
  • Parkinson's Disease (1)
  • Pediatric (3)
  • Transplant (2)

KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in Rituximab (Rituxan) (10)

Friday
Apr012011

NCT01329354

Rituximab and Autologous Effector Lymphocytes in Non-Hodgkins Follicular Lymphoma in Response to First Line Chemotherapy

Conditions: Non-Hodgkin Lymphoma
Sponsors: Clinica Universidad de Navarra, Universidad de Navarra
Phase: II 

Date: DateApril 1, 2011
Categories CategoryCancer - Lymphoma
Tags ,
Tuesday
Jul312007

NCT00510471

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Conditions: Non-Hodgkin's Lymphoma
Sponsors: Genitope Corporation
Phase II

Date: DateJuly 31, 2007
Categories CategoryCancer - Lymphoma
Tags , , , ,
Wednesday
May102006

NCT00324831

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Conditions: Lymphoma
Sponsors: Favrille
Phase III

Date: DateMay 10, 2006
Categories CategoryCancer - Lymphoma
Tags , , , ,
Wednesday
Jan042006

NCT00282308

A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate

Conditions: Rheumatoid Arthritis
Sponsors: Genentech
Phase II

Date: DateJanuary 4, 2006 | Reference1 Reference
Categories CategoryArthritis, CategoryImmune Disease - Autoimmune
Tags , ,
Tuesday
Nov222005

NCT00258336

Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma

Conditions: Lymphoma 
Sponsors: Favrille
Phase II

Date: DateNovember 22, 2005
Categories CategoryCancer - Lymphoma
Tags , , , ,
Wednesday
Apr132005

A Multicenter Study to Evaluate the Effect of Rituximab (IDEC-102) on Primary Humoral Response, Recall Response, and Maintenance of Acquired Immunity to Specific Antigens

Conditions: Non-Hodgkin’s Lymphoma
Sponsors: Biogen Idec Inc
Phase n/a

Date: DateApril 13, 2005
Categories CategoryCancer - Lymphoma
Tags , ,
Monday
Aug232004

NCT00090038

Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

Conditions: Non-Hodgkin's Lymphoma
Sponsors: Biogen Idec
Phase IV

Date: DateAugust 23, 2004
Categories CategoryCancer - Lymphoma
Tags , ,
Wednesday
Aug042004

NCT00089115

Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

Conditions: Lymphoma
Sponsors: Favrille
Phase III

Date: DateAugust 4, 2004 | Reference1 Reference
Categories CategoryCancer - Lymphoma
Tags , , , ,
Tuesday
Nov042003

NCT00071955

Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma

Conditions: Lymphoma
Sponsors: Genitope Corporation
Phase II

Date: DateNovember 4, 2003 | Reference1 Reference
Categories CategoryCancer - Lymphoma
Tags , , , ,
Tuesday
May062003

NCT00060164

Rituximab, Autologous Vaccine Therapy, and Sargramostim in Treating Patients With Recurrent or Refractory Follicular B-Cell Lymphoma

Conditions:  Lymphoma
Sponsors:  Univeristy Hospitals Seidman Cancer Center, National Cancer Institute (NCI)
Phase II

Date: DateMay 6, 2003
Categories CategoryCancer - Lymphoma
Tags , , , ,